⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RIGL News
Rigel Pharmaceuticals Inc. (New)
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
prnewswire.com
RIGL
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
prnewswire.com
RIGL
Rigel to Present at the Jefferies Global Healthcare Conference in London
prnewswire.com
RIGL
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update
prnewswire.com
RIGL
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
prnewswire.com
RIGL
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
prnewswire.com
RIGL
RIGL
Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
prnewswire.com
RIGL
RIGL
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
prnewswire.com
RIGL
RIGL
Rigel to Participate in Upcoming September Investor Conferences
prnewswire.com
RIGL
RIGL